Bone loss in long-term renal transplantation: Histopathology and densitometry analysis

Kidney International

Volumn 55, Issue 5, 1999, Pages 2021-2029

  Cueto Manzano, Alfonso M ^a,b   Konel, Shaikh ^a,b   Hutchison, Alastair J ^a,b   Crowley, Vivion ^a,b   France, Michael W ^a,b   Freemont, Anthony J ^a,b   Adams, Judith E ^a,b   Mawer, Barbara ^a,b   Gokal, Ram ^a,b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bone mineral density; Cyclosporine A; Glucocorticoids; Immunosuppression; Osteoblast; Osteoclast; Renal osteodystrophy

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE;

ADULT; ARTICLE; BONE ATROPHY; BONE BIOPSY; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; DENSITOMETRY; FEMALE; HUMAN; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; MALE; OSTEODYSTROPHY; OSTEOPENIA; PRIORITY JOURNAL; UREMIA;

EID: 0032917787     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00445.x     Document Type: Article

References (38)

1. 1. MALLUCHE H, FAUGERE MC: Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 38:193-211, 1990
2. 2. DELMEZ JA, SLATOPOLSKY E, MARLIN KJ, GEARING BN, HARTER HR: Minerals, vitamin D and parathyroid hormone in continuous ambulatory peritoneal dialysis. Kidney Int 21:862-867, 1982
3. 3. HUFFER WE, KUZELA D, POPOVTZE MM, STARZL TE: Metabolic bone disease in chronic renal failure. II. Renal transplant patients. Am J Pathol 78:385-400, 1975
4. 4. MAIN J, VELASCO N, CATTO GR, FRASER RA, EDWARD N, ADAMI S, O'RIODAN JL: The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: A computerized histomorphometric analysis. Clin Nephrol 26:279-287, 1986
5. 5. SHANE E, RIVAS M, SILVERBERG S, KIM T, STARON R, BILEZIKIAN J: Osteoporosis after cardiac transplantation. Am J Med 94:257-264, 1993
6. 6. MCDONALD J, DUNSTAN C, DlLWORTH P, SHERBON K, SHEIL AG, EVANS RA, MCCAUGHAN GW: Bone loss after liver transplantation. Hepatology 14:613-619, 1991
7. 7. GROTZ WH, MUNDINGER FA, GUGEL B, EXNER V, KIRSTE G, SCHOLLMEYER PJ: Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant patients. Transplantation 58:912-915, 1994
8. 8. JULIAN BA, LASKOW DA, DUBOVSKY J, CURTIS J, QUARLES D: Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544-550, 1991
9. 9. HOSBER FF, CASEZ JP, STEIGER U, CZEERNIAK A, MONTANDON A, JAEGER PD: Changes in bone mass early after kidney transplantation. J Bone Miner Res 9:1-9, 1994
10. 10. ALMOND MK, KWAN JTC, EVANS K, CUNNINGHAM J: Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 66:52-57, 1994
11. 11. GROTZ WH, MUNDINGER FA, RASENACK J, SPEIDEL L, OLSCHEWSKI M, EXNER VM, SCHOLLMEYER PJ: Bone loss after kidney transplantation: A longitudinal study in 115 graft recipients. Nephrol Dial Transplant 10:2096-2100, 1995
12. 12. PICHETTE V, BONNARDEAUX A, PRUDHOMME L, GAGNÉ M, CARDICNAL J, OUIMET D: Long-term bone loss in kidney transplant recipients: A cross-sectional and longitudinal study. Am J Kidney Dis 28:105-111, 1996
13. 13. SLATOPOLSKY E, MARTIN K: Glucocorticoids and renal transplant osteonecrosis. Adv Exp Med Biol 171:353-359, 1984
14. 14. LUCKERT BP, RAISZ LG: Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112:352-364,1990
15. 15. EPSTEIN S: Cyclosporin A: Friend or foe? Calcif Tissue Int 49:232-234, 1991
16. 16. AUBIA J, MASRAMÓN J, SERRANO S, LLOVERAS J, MARIÑOSO LL: Bone histology in renal transplant patients receiving cyclosporin. Lancet 1:1048-1049, 1988
17. 17. BRINER VA, THIEL G, MONIER-FAUGERE MC, BOGNAR B, LANDMANN J, KAMBER V, MALLUCHE HH: Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation. Transplantation 10:1393-1400, 1995
18. 18. WOLPAW T, DEAL CL, FLEMING-BROOKS S, BARTUCCI MR, SCHULAK J, HRICIK DE: Factors influencing vertebral bone density after renal transplantation. Transplantation 58:1186-1189, 1994
19. 19. TORREGROSA JV, CAMPISTOL JM, MONTESINOS M, PONS M, MARINES DE OSABA MJ: Evolution of bone mineral density after renal transplantation: Related factors. Nephrol Dial Transplant 10(Suppl 6):111-113, 1995
20. 20. AROLDI A, TARANTINO A, MONTAGNINO G, CESANA B, COCUCCI C, PONTICELLI C: Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients. Transplantation 63:380-386, 1997
21. 21. MALLUCHE HH, MONIER-FAUGERE MC: The role of bone biopsy in the management of patients with renal osteodystrophy. J Am Soc Nephrol 4:1631-1642, 1994
22. 22. SANCHEZ CP, SALUSKY IB, KUIZON BD, RAMIREZ JA, GALES B, ETTENGER RB, GOODMAN WG: Bone disease in children and adolescents undergoing successful renal transplantation. Kidney Int 53:1358-1364, 1998
23. 3 and radiology in end-stage renal disease. Kidney Int 44:1071-1077, 1993
24. 24. REHMAN MTA, HOYLAND JA, DENTON J, FREEMONT AJ: Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 47:529-534, 1994
25. 25. PARFITT AM, DREZNER MK, GLORIEUX FH, KANIS JA, MALLUCHE H, MEUNIER PJ, OTT SM, RECKER RR: Bone histomorphometry: Standardization of nomenclature, symbols and units. J Bone Miner Res 2:595-610, 1987
26. 26. RIGGS BL, WAHNER W, SEEMANN E: Changes in bone mineral density of the proximal femur and spine with aging. J Clin Invest 70:716-723, 1982
27. 27. WORLD HEALTH ORGANISATION: Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. Technical report series, Geneva, WHO, 1994, p 843
28. 28. ADAMS JE: Single-and dual-energy: X-ray absorptiometry, in Dual Energy X-ray Absorptiometry in Osteoporosis and Bone Densitometry, edited by Genant HK, Guglielmo G, Jergas M, Berlin, Springer-Verlag, 1997, pp 305-334
29. 29. VELAZQUEZ-FORERO F, MONDRAGON A, HERRERO B, PEÑA JC: Adynamic bone lesion in renal transplanted recipients with normal renal function. Nephrol Dial Transplant 11(Suppl 3):58-64, 1996
30. 30. RODINO MA, SHANE E: Osteoporosis after organ transplantation. Am J Med 104:459-469, 1998
31. 31. MOVSOWITZ C, EPSTEIN S, FALLON M, ISMAIL F, THOMAS S: Cyclosporin-A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration. Endocrinology 123:2571-2577, 1988
32. 32. STEIN B, HALLORAN BP, REINHARDT T, ENGSTROM GW, BATES CW, DREZNER MK, CURRIA KL, TAKIZAWA M, ADAMS JS, EPSTEIN S: Cyclosporin-A increases synthesis of 1-25 dihydroxyvitamin D3 in the rat and mouse. Endocrinology 128:1369-1373, 1991
33. 33. STEWART PJ, GREEN OC, STERN PH: Cyclosporin-A inhibits hormone induced bone resorption in-vitro. J Bone Miner Res 1:285-291, 1986
34. 34. KLAUSHOFER K, HOFFMAN O, STEWART PJ, CZERWENKA E, KOLLER K, PETERTIK M, STERN PH: Cyclosporin-A inhibits bone resorption in cultured neonatal mouse calvariae. J Pharmacol Exp Ther 243:584-590, 1987
35. 35. ORCET P, DENNE MA, DE VERNEJOUT MC: Cyclosporine-A in-vitro decreases bone resorption, osteoclast formation and the fusion of cells of the monocyte-macrophage lineage. Endocrinology 128: 1638-1646, 1991
36. 36. BILEZIKIAN JP: Primary hyperparathyroidism, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, edited by Favus MJ, Philadelphia, Lippincott-Raven, 1996, pp 181-186
37. 37. KRONENBERG HM: Parathyroid hormone: Mechanism of action, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, edited by Favus MJ, Philadelphia, Lippincott-Raven, 1996, pp 68-73
38. 38. RISTELI J, ELOMAA I, NIEMI S, NOVAMO A, RISTELI L: Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39:635-640, 1993